Aik Choon Tan Selected Research

Aik Choon Tan Research Topics

Disease

60	Neoplasms (Cancer) 02/2024 - 10/2005
15	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 06/2010
12	Squamous Cell Carcinoma of Head and Neck 01/2024 - 01/2013
9	Melanoma (Melanoma, Malignant) 05/2023 - 01/2016
9	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2012
7	Pancreatic Neoplasms (Pancreatic Cancer) 09/2011 - 04/2008
5	Triple Negative Breast Neoplasms 11/2019 - 01/2013
4	Breast Neoplasms (Breast Cancer) 09/2023 - 02/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 08/2012
3	Adenocarcinoma 10/2023 - 11/2009
3	Anaplastic Thyroid Carcinoma 01/2023 - 01/2016
3	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 01/2016
2	Disease Progression 09/2023 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2008
2	Inflammation (Inflammations) 01/2021 - 12/2016
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2019 - 10/2015
2	Leukemia 12/2015 - 04/2013
1	Papillary Thyroid Cancer 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Multiple Myeloma 01/2023
1	Thyroid Diseases (Thyroid Disease) 01/2021

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2009
12	Phosphotransferases (Kinase)IBA 12/2019 - 01/2013
9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021 - 04/2008
7	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2018
7	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2008
4	pembrolizumabIBA 10/2023 - 01/2023
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023 - 04/2013
4	Dasatinib (BMS 354825)FDA Link 01/2023 - 01/2016
4	ErbB Receptors (EGF Receptor)IBA 12/2019 - 04/2008
3	Estrogen ReceptorsIBA 09/2023 - 01/2013
3	Steroid Receptors (Steroid Receptor)IBA 09/2023 - 02/2012
3	Estrogens (Estrogen)FDA Link 09/2023 - 02/2012
3	Cetuximab (Erbitux)FDA Link 01/2023 - 04/2008
3	Tyrosine Kinase InhibitorsIBA 05/2021 - 11/2013
3	bosutinibIBA 01/2017 - 06/2009
3	AZD 6244IBA 11/2013 - 12/2010
3	Small Interfering RNA (siRNA)IBA 08/2013 - 01/2012
3	saracatinibIBA 05/2012 - 06/2009
3	Gemcitabine FDA Link 09/2011 - 04/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023 - 11/2010
2	Thyroid HormonesIBA 09/2023 - 01/2021
2	Tamoxifen FDA LinkGeneric 09/2023 - 01/2021
2	trametinibIBA 01/2023 - 10/2021
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2021
2	cabozantinibIBA 01/2023 - 04/2015
2	ChemokinesIBA 01/2023 - 01/2020
2	InterferonsIBA 01/2023 - 05/2021
2	Drug CombinationsIBA 01/2022 - 01/2015
2	CytokinesIBA 01/2021 - 12/2016
2	Protein Kinases (Protein Kinase)IBA 12/2019 - 10/2015
2	Mitogen-Activated Protein KinasesIBA 12/2019 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 09/2018 - 05/2013
2	Anaplastic Lymphoma KinaseIBA 02/2018 - 10/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2005
2	ENMD 2076IBA 01/2017 - 01/2013
2	MLN 8237IBA 08/2016 - 05/2015
2	LigandsIBA 01/2016 - 08/2013
2	ponatinibIBA 12/2015 - 10/2015
2	Aurora Kinase AIBA 05/2015 - 01/2015
2	Gefitinib (Iressa)FDA Link 09/2014 - 04/2013
2	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 11/2013 - 11/2010
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2012 - 11/2010
2	MicroRNAs (MicroRNA)IBA 01/2012 - 11/2009
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2010 - 06/2010
1	NucleotidesIBA 02/2024
1	Capecitabine (Xeloda)FDA Link 10/2023
1	ParaffinIBA 05/2023
1	Formaldehyde (Formol)FDA Link 05/2023
1	NivolumabIBA 01/2023
1	talazoparibIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	olaparibIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Melphalan (Alkeran)FDA LinkGeneric 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2022
1	IpilimumabIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 12/2021
1	Small Cytoplasmic RNAIBA 10/2021
1	palbociclibIBA 10/2021
1	osimertinibIBA 05/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	prexasertibIBA 01/2021
1	Checkpoint Kinase 1IBA 01/2021
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	SmokeIBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2019
1	Sirolimus (Rapamycin)FDA Link 12/2019
1	RX-5902IBA 11/2019
1	CateninsIBA 11/2019

Therapy/Procedure

35	Therapeutics 01/2024 - 02/2008
7	Immunotherapy 01/2024 - 11/2018
6	Drug Therapy (Chemotherapy) 10/2023 - 11/2010
6	Precision Medicine 01/2021 - 09/2014
3	Aftercare (After-Treatment) 01/2023 - 06/2012
1	Salvage Therapy 10/2021
1	Duration of Therapy 01/2021